Detect Stock

Detect Inc., headquartered in Guilford, Connecticut, is at the forefront of making high-quality diagnostic testing accessible and convenient. Founded in response to the Covid-19 pandemic, the company initially developed a rapid at-home molecular test for Covid-19, blending the accuracy of lab testing with the ease of at-home use. This innovative approach enabled individuals to obtain PCR-quality results within minutes, revolutionizing home diagnostics. Leveraging isothermal amplification technology, Detect’s tests deliver highly accurate results without the complexities and costs associated with traditional lab processes. Their platform incorporates custom enzymes and dyes, ensuring minimal sample preparation and rapid real-time results. This not only enhances accuracy but also reduces testing time and expenses. The company’s second-generation diagnostic platform aims to extend its offerings to include tests for common infections, particularly focusing on sexual and family health. Detect’s advanced molecular platform supports multiplex testing from a single sample, enhancing efficiency and expanding its application scope. Detect's AI-driven primer design further accelerates the development of new test products, allowing rapid adaptation to emerging pathogens and variants. The team behind Detect comprises passionate scientists, engineers, and designers dedicated to improving healthcare accessibility and effectiveness through innovative diagnostic solutions. With its commitment to combining speed, accuracy, and convenience, Detect is poised to make significant contributions to the future of diagnostic testing.